‘Snowflake’ Nanoparticle Boosts Cancer Therapy
A snowflake-shaped nanoparticle greatly enhanced the combination of radiotherapy and immunotherapy in mouse models of prostate cancer.
Browsing: "Nanotechnology"
‘Epidermal VR’ Gives Technology a Human Touch
Northwestern University scientists have developed a new thin, wireless system that adds a sense of touch to any virtual reality experience, adding sensory feedback to prosthetics.
Vaccine Design May Dramatically Improve Cancer Immunotherapies
The structure of spherical nucleic acids has the potential to improve the effectiveness of vaccines as well as cancer immunotherapies, according to a new study.
World’s Smallest Wearable Device Warns of UV Exposure, Enables Precision Phototherapy
The world’s smallest wearable device has been developed by Northwestern scientists, to measure exposure to light across multiple wavelengths.
New Bio-Inspired Dynamic Materials Transform Themselves
Scientists have developed soft materials that assemble and disassemble on demand, opening the door for applications including robotics, drug delivery and tissue regeneration.
PhD Student Explores Role of Exosomes in Cancer Metastasis
Northwestern Medicine scientists have demonstrated that tiny vesicles called exosomes released from non-metastatic melanoma cells trigger an immune response that prevents cancer from spreading throughout the body.
Nanoshells Provide New Approach to Targeted Chemotherapy Delivery
A team of scientists has demonstrated a novel approach to delivering cancer drugs directly to tumor cells, through gold nanoparticles that can be remotely triggered to release therapies.
Nanomedicine Opens Door to Precision Medicine for Brain Tumors
Early phase Northwestern Medicine research has demonstrated a potential new therapeutic strategy for treating glioblastoma.
First Spherical Nucleic Acid Drug Injected into Humans Targets Brain Cancer
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
Scientists Develop Novel Platform to Investigate Therapeutic Nanomaterials
Northwestern Medicine scientists have developed a novel testing platform to assess, in real time, the efficacy of nanomaterials in regulating gene expression.